Stem Cells to Organoids: Pioneering the Future of Regenerative Therapies
Stem Cell Reviews and Reports · 2026-01 · 22 (1) · 118-143
DOI: 10.1007/s12015-025-10985-7 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Stem Cell Reviews and Reports, online erschienen am 09.10.2025. Verfasst von Dinesh Kumar und 5 weiteren Autor:innen. Beteiligte Einrichtung: GNA School of Pharmacy, GNA University, Phagwara, Punjab, India. dineshpotlia123@gmail.com. Hauptthemen laut MEDLINE: Organoids, Regenerative Medicine, Stem Cells. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 174 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: Understanding normal development, disease modeling, and regenerative medicine forms the cornerstone of modern biomedical research. Insights into embryonic and postnatal development enable the study of cellular processes critical for tissue and organ formation. OBJECTIVES: This review aims to summarize recent advancements in developmental biology, disease modeling techniques, and regenerative medicine, emphasizing the integration of these fields to improve therapeutic strategies. METHODS: A comprehensive literature analysis was conducted focusing on stem cell biology, tissue engineering, organoid technology, and bioengineering approaches relevant to normal development, disease modeling, and regenerative therapies. RESULTS: Advances in stem cell technologies, including embryonic and induced pluripotent stem cells, have facilitated transplantation therapies and tissue regeneration. The emergence of 3D multicellular culture systems, such as organoids, enhances disease modeling by more accurately replicating tissue architecture. Bioengineered organ germs represent a promising strategy for functional organ regeneration. However, challenges remain in mimicking the complex in vivo environment and addressing ethical and technical limitations. CONCLUSIONS: Multicellular and three-dimensional in vitro models represent critical tools for bridging gaps in our understanding of development, disease, and regeneration. Continued interdisciplinary efforts are essential to translate these findings into effective regenerative therapies and precise disease models.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- GNA School of Pharmacy, GNA University, Phagwara, Punjab, India. dineshpotlia123@gmail.com.
- Swami Devi Dyal Group of Professional Institute, Panchkula, India.
- School of Pharmacy, Desh Bhagat University, Mandi Gobindgarh, Punjab, India.
- Department of Pharmaceutical Sciences, Guru Jambheswar University, Hisar, Haryana, India.
- Chandigarh Group of Colleges, Jhanjeri, Mohali, Punjab, India.
ORCID-Profile: Dinesh Kumar, Sonia Gupta, Vrinda Gupta, Rajni Tanwar, Pooja Rani
Zitieren
APA
Kumar, D., Gupta, S., Gupta, V., Tanwar, R., Rani, P., & Bansal, V. (2026). Stem Cells to Organoids: Pioneering the Future of Regenerative Therapies. Stem Cell Reviews and Reports, 22(1), 118-143. https://doi.org/10.1007/s12015-025-10985-7
Vancouver
Kumar D, Gupta S, Gupta V, Tanwar R, Rani P, Bansal V. Stem Cells to Organoids: Pioneering the Future of Regenerative Therapies. Stem Cell Reviews and Reports. 2026;22(1):118-143. doi:10.1007/s12015-025-10985-7
BibTeX
@article{Kumar2026,
author = {Kumar, Dinesh and Gupta, Sonia and Gupta, Vrinda and Tanwar, Rajni and Rani, Pooja and Bansal, Vikas},
title = {Stem Cells to Organoids: Pioneering the Future of Regenerative Therapies},
journal = {Stem Cell Reviews and Reports},
year = {2026},
volume = {22},
number = {1},
pages = {118--143},
doi = {10.1007/s12015-025-10985-7}
}
EUVIMED